Lantheus Holdings Inc (LNTH)
90.52
+3.20
(+3.66%)
USD |
NASDAQ |
Nov 22, 16:00
90.55
+0.03
(+0.03%)
After-Hours: 20:00
Lantheus Holdings Total Assets (Quarterly): 2.050B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 2.050B |
June 30, 2024 | 1.940B |
March 31, 2024 | 1.831B |
December 31, 2023 | 1.651B |
September 30, 2023 | 1.522B |
June 30, 2023 | 1.338B |
March 31, 2023 | 1.349B |
December 31, 2022 | 1.321B |
September 30, 2022 | 1.096B |
June 30, 2022 | 1.014B |
March 31, 2022 | 933.17M |
December 31, 2021 | 863.78M |
September 30, 2021 | 847.82M |
June 30, 2021 | 857.80M |
March 31, 2021 | 843.45M |
December 31, 2020 | 869.82M |
September 30, 2020 | 879.59M |
June 30, 2020 | 879.70M |
March 31, 2020 | 404.12M |
December 31, 2019 | 405.92M |
September 30, 2019 | 402.41M |
June 30, 2019 | 390.25M |
Date | Value |
---|---|
March 31, 2019 | 443.91M |
December 31, 2018 | 439.83M |
September 30, 2018 | 424.82M |
June 30, 2018 | 401.80M |
March 31, 2018 | 392.59M |
December 31, 2017 | 383.86M |
September 30, 2017 | 281.02M |
June 30, 2017 | 267.88M |
March 31, 2017 | 249.56M |
December 31, 2016 | 255.90M |
September 30, 2016 | 254.97M |
June 30, 2016 | 259.27M |
March 31, 2016 | 249.26M |
December 31, 2015 | 242.38M |
September 30, 2015 | 236.13M |
June 30, 2015 | 233.55M |
March 31, 2015 | 250.66M |
December 31, 2014 | 243.15M |
September 30, 2014 | 259.98M |
June 30, 2014 | 255.24M |
March 31, 2014 | 260.96M |
December 31, 2013 | 261.31M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
404.12M
Minimum
Mar 2020
2.050B
Maximum
Sep 2024
1.145B
Average
973.50M
Median
Total Assets (Quarterly) Benchmarks
Perspective Therapeutics Inc | 391.15M |
Pulmonx Corp | 167.40M |
RxSight Inc | 310.47M |
PROCEPT BioRobotics Corp | 374.14M |
Electromed Inc | 48.92M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 869.92M |
Shareholders Equity (Quarterly) | 1.180B |
Debt to Equity Ratio | 0.4792 |
Current Ratio | 1.652 |
Net Debt Paydown Yield | -0.02% |